Description
EMPAMET XR Tablets 25mg + 1000mg (14’s pack) combine Empagliflozin and Metformin extended-release to provide effective management of type 2 diabetes mellitus. Each tablet contains 25mg of Empagliflozin, an SGLT2 inhibitor that promotes glucose excretion through the kidneys, and 1000mg of Metformin in extended-release form, which reduces hepatic glucose production and improves insulin sensitivity.
This combination supports sustained blood sugar control, aids in weight management, and may offer cardiovascular benefits. The extended-release formulation ensures gradual medication release, enhancing patient compliance and reducing gastrointestinal side effects.
Manufactured under stringent quality standards, EMPAMET XR Tablets ensure safety, efficacy, and consistent therapeutic performance. Patients should follow their healthcare provider’s instructions and maintain a healthy lifestyle for optimal results.
Reviews
There are no reviews yet.